Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromocriptine reduces rat thyrotropin beta-subunit mRNA stability.

A Levy1, S L Lightman

  • 1Medical Unit, Charing Cross and Westminster Medical School, London, England.

Journal of Endocrinological Investigation
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential expression of sialyl and non-sialyl-CD15 antigens on Hodgkin-Reed-Sternberg cells: significance in Hodgkin's disease.

Leukemia & lymphoma·2000
Same author

[Severe obstetric complications nescessitating hospitalization and intensive care: a ten year retrospective study].

Annales francaises d'anesthesie et de reanimation·2000
Same author

The effects of acute and chronic stresses on vasotocin gene transcripts in the brain of the rainbow trout (Oncorhynchus mykiss).

Journal of neuroendocrinology·2000
Same author

Mitosis and apoptosis in the pituitary gland: tumour formation or hyperplasia?

Bailliere's best practice & research. Clinical endocrinology & metabolism·2000
Same author

["Stigma 2000"--is a change of direction really necessary?].

Harefuah·2000
Same author

Production of interleukin-1-like molecules by human sperm cells.

Fertility and sterility·2000

Bromocriptine significantly reduces thyroid-stimulating hormone beta-subunit mRNA in rat pituitary glands. This effect involves altered mRNA stability, suggesting dopamine regulates TSH metabolism via mRNA catabolism.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Neuroendocrinology

Background:

  • Thyroid-stimulating hormone (TSH) is crucial for thyroid function.
  • Dopamine is known to inhibit TSH secretion.
  • The precise molecular mechanisms of dopamine's effect on TSH are not fully understood.

Purpose of the Study:

  • To investigate the effect of bromocriptine, a dopamine agonist, on TSH beta-subunit mRNA levels in rat anterior pituitary glands.
  • To elucidate the role of mRNA stability in the regulation of TSH beta-subunit by dopamine.

Main Methods:

  • Oral administration of bromocriptine to Sprague-Dawley rats.
  • In situ hybridization histochemistry to quantify TSH beta-subunit mRNA in pituitary sections.
  • Dot-blot analysis of nuclear and cytoplasmic pituitary extracts.

Related Experiment Videos

  • Culture of pituitary cells under actinomycin D to assess mRNA stability.

    • Main Results:

    • Bromocriptine administration (10 mg/kg/day) resulted in a 60% reduction in TSH beta-subunit mRNA probe binding.
    • Dot-blot analysis confirmed the reduction in both nuclear and cytoplasmic fractions.
    • Bromocriptine treatment altered TSH beta-subunit mRNA stability, indicating a role in mRNA catabolism.

    Conclusions:

    • Bromocriptine acutely reduces TSH beta-subunit mRNA levels in the anterior pituitary.
    • Dopamine's acute influence on TSH metabolism may be mediated by controlling TSH beta-subunit mRNA catabolism.
    • This provides a mechanism for rapid cellular response to hormonal effects at the transcriptional level, even with stable mRNAs.